Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Clinical trial NCT03098589 · COMPLETED
Trial details
- NCT number
- NCT03098589
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-05-30
- Primary completion
- 2020-09-18
- Enrollment
- 1149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.